
Budison-FG(4.8 mcg+9
Aristopharma Ltd.
Formoterol Fumarate + Glycopyrrolate + Budesonide is an FDA-approved, guideline-supported triple fixed-dose combination inhaler indicated for the long-term and more.
Formoterol Fumarate + Glycopyrrolate + Budesonide is an FDA-approved, guideline-supported triple fixed-dose combination inhaler indicated for the long-term, twice-daily maintenance treatment of two chronic obstructive airway diseases. It is not a rescue inhaler and must not be used to relieve sudden breathing problems.
Formoterol Fumarate + Glycopyrrolate + Budesonide is always used as maintenance/controller therapy and is prescribed by a physician after assessment of disease severity.
Formoterol Fumarate + Glycopyrrolate + Budesonide is administered by oral inhalation only, using the actuator provided. It must be used regularly, twice daily, approximately 12 hours apart, and not more often than prescribed.
| Indication | Recommended Dose |
|---|---|
| COPD (adults) | 2 oral inhalations twice daily (morning and evening) |
| Asthma (adults and adolescents ≥12 years) | 2 oral inhalations twice daily (morning and evening) |
The exact delivered strength of Formoterol Fumarate + Glycopyrrolate + Budesonide per actuation differs between the COPD-indicated product and the asthma-indicated product; patients should use only the specific inhaler strength prescribed for their condition and should not exceed 2 inhalations twice daily (maximum 4 inhalations per day).
If a dose of Formoterol Fumarate + Glycopyrrolate + Budesonide is missed, it should be taken as soon as remembered; if it is almost time for the next dose, the missed dose should be skipped. Do not double the dose.
Formoterol Fumarate + Glycopyrrolate + Budesonide should never be used for sudden shortness of breath; a separate fast-acting rescue inhaler should always be available.
Most people tolerate Formoterol Fumarate + Glycopyrrolate + Budesonide well, but side effects can occur.
Serious risks such as paradoxical bronchospasm, cardiovascular effects, pneumonia (in COPD patients), hypersensitivity reactions, and effects on the adrenal glands and bone density are discussed in detail under Precautions and Warnings.
Patients should contact their physician promptly if side effects are severe, persistent, or concerning.
Formoterol Fumarate + Glycopyrrolate + Budesonide is contraindicated in:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.